M Ventures

M Ventures is the strategic corporate venture capital arm of Merck KGaA, Darmstadt, Germany, founded in 2009 as Merck Serono Ventures. Headquartered in Amsterdam with offices in Germany, the US, and Israel, it operates as an evergreen fund with a €600M allocation announced in December 2021. It invests globally across two broad verticals: Biotechnology (Healthcare drug development and Life Science tools) and Technology (Electronics and Frontier Technology & Sustainability). The fund pursues dual strategic and financial objectives, backing visionary companies at seed stage through later rounds, including Merck KGaA spin-offs. With over 100 total investments, M Ventures takes an active board-level role in portfolio companies and co-invests alongside other VCs. There is no public application portal; founders typically engage through the team directly or via the contact page on the website.